Renaissance Technologies LLC 13D and 13G filings for Salarius Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-02-12 6:58 pm Purchase | 2019-12-31 | 13G | Salarius Pharmaceuticals, Inc. SLRX | Renaissance Technologies LLC | 294 1.450% | 294 (New Position) | Filing |